Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1981 Feb;19(2):326–327. doi: 10.1128/aac.19.2.326

Analysis of the in vitro interaction between vancomycin and cholestyramine.

C Y King, S L Barriere
PMCID: PMC181420  PMID: 6812491

Abstract

Vancomycin and cholestyramine have been utilized both alone and in combination for the treatment of antibiotic-associated pseudomembranous colitis. Previous work for the treatment of antibiotic-associated pseudomembranous colitis. Previous work has demonstrated significant binding of vancomycin by the anion-exchange resin. The antibacterial activity of vancomycin was markedly reduced when the suspension was centrifuged and the supernatant was tested for antibacterial activity. This study confirmed these findings but demonstrated that there was no immediate loss of antibacterial activity of bound vancomycin. The degree of inactivation appeared to be dependent upon the duration of incubation of vancomycin and cholestyramine in the testing system.

Full text

PDF
327

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartlett J. G. Antibiotic-associated pseudomembranous colitis. Rev Infect Dis. 1979 May-Jun;1(3):530–539. doi: 10.1093/clinids/1.3.530. [DOI] [PubMed] [Google Scholar]
  2. Bartlett J. G., Chang T. W., Gurwith M., Gorbach S. L., Onderdonk A. B. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med. 1978 Mar 9;298(10):531–534. doi: 10.1056/NEJM197803092981003. [DOI] [PubMed] [Google Scholar]
  3. Bartlett J. G., Tedesco F. J., Shull S., Lowe B., Chang T. Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis. Gastroenterology. 1980 Mar;78(3):431–434. [PubMed] [Google Scholar]
  4. GERACI J. E., HEILMAN F. R., NICHOLS D. R., ROSS G. T., WELLMAN W. E. Some laboratory and clinical experiences with a new antibiotic, vancomycin. Proc Staff Meet Mayo Clin. 1956 Oct 17;31(21):564–582. [PubMed] [Google Scholar]
  5. George R. H., Youngs D. J., Johnson E. M., Burdon D. W. Anion-exchange resins in pseudomembranous colitis. Lancet. 1978 Sep 16;2(8090):624–624. doi: 10.1016/s0140-6736(78)92840-4. [DOI] [PubMed] [Google Scholar]
  6. George W. L., Rolfe R. D., Mulligan M. E., Finegold S. M. Infectious diseases 1979--antimicrobial agent-induced colitis: an update. J Infect Dis. 1979 Aug;140(2):266–268. doi: 10.1093/infdis/140.2.266. [DOI] [PubMed] [Google Scholar]
  7. George W. L., Volpicelli N. A., Stiner D. B., Richman D. D., Liechty E. J., Mok H. Y., Rolfe R. D., Finegold S. M. Relapse of pseudomembranous colitis after vancomycin therapy. N Engl J Med. 1979 Aug 23;301(8):414–415. doi: 10.1056/NEJM197908233010806. [DOI] [PubMed] [Google Scholar]
  8. Keighley M. R., Burdon D. W., Arabi Y., Williams J. A., Thompson H., Youngs D., Johnson M., Bentley S., George R. H., Mogg G. A. Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea. Br Med J. 1978 Dec 16;2(6153):1667–1669. doi: 10.1136/bmj.2.6153.1667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Mann J. M., Coleman D. L., Boylan J. C. Stability of parenteral solutions of sodium cephalothin, cephaloridine, potassium penicillin G (buffered) and vancomycin hydrochloride. Am J Hosp Pharm. 1971 Oct;28(10):760–763. [PubMed] [Google Scholar]
  10. Taylor N. S., Bartlett J. G. Binding of Clostridium difficile cytotoxin and vancomycin by anion-exchange resins. J Infect Dis. 1980 Jan;141(1):92–97. doi: 10.1093/infdis/141.1.92. [DOI] [PubMed] [Google Scholar]
  11. Tedesco F. J., Napier J., Gamble W., Chang T. W., Bartlett J. G. Therapy of antibiotic-associated pseudomembranous colitis. J Clin Gastroenterol. 1979 Mar;1(1):51–54. doi: 10.1097/00004836-197903000-00007. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES